Efficacy and safety of RET-TKI in advanced RET-rearranged non-small cell lung cancer in China: a real-world retrospective chart review

Efficacy and safety of RET-TKI in advanced RET-rearranged non-small cell lung cancer in China: a real-world retrospective chart review

Abstract Background Selective RET inhibitors have been approved by the Chinese government for the treatment of RET-rearranged non-small cell lung cancer. This study aimed to illustrate the efficacy and safety of selective RET inhibitors in a real-world clinical context in China. Methods Patients wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Siyu Lei, Linyan Tian, Lu Yang, Yaning Yang, Junling Li, Xingsheng Hu, Xuezhi Hao, Haiyan Xu, Yan Wang
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Cancer
Subjects:
Non-small cell lung cancer
RET rearrangement
RET-TKI
Real-world study
Online Access:https://doi.org/10.1186/s12885-024-13155-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-024-13155-z

Similar Items